JP2012518646A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518646A5
JP2012518646A5 JP2011551250A JP2011551250A JP2012518646A5 JP 2012518646 A5 JP2012518646 A5 JP 2012518646A5 JP 2011551250 A JP2011551250 A JP 2011551250A JP 2011551250 A JP2011551250 A JP 2011551250A JP 2012518646 A5 JP2012518646 A5 JP 2012518646A5
Authority
JP
Japan
Prior art keywords
blastomere
stem cells
drug according
cells
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011551250A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012518646A (ja
JP5809068B2 (ja
Filing date
Publication date
Priority claimed from US12/391,581 external-priority patent/US8563307B2/en
Application filed filed Critical
Publication of JP2012518646A publication Critical patent/JP2012518646A/ja
Publication of JP2012518646A5 publication Critical patent/JP2012518646A5/ja
Application granted granted Critical
Publication of JP5809068B2 publication Critical patent/JP5809068B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011551250A 2009-02-24 2010-02-19 免疫抑制−関連疾患の治療 Expired - Fee Related JP5809068B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/391,581 US8563307B2 (en) 2009-02-24 2009-02-24 Treatment of immunosuppression-related disorders
US12/391,581 2009-02-24
PCT/US2010/024735 WO2010099044A2 (en) 2009-02-24 2010-02-19 Treatment of immunosuppression-related disorders

Publications (3)

Publication Number Publication Date
JP2012518646A JP2012518646A (ja) 2012-08-16
JP2012518646A5 true JP2012518646A5 (enExample) 2012-11-29
JP5809068B2 JP5809068B2 (ja) 2015-11-10

Family

ID=42631141

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011551250A Expired - Fee Related JP5809068B2 (ja) 2009-02-24 2010-02-19 免疫抑制−関連疾患の治療

Country Status (7)

Country Link
US (2) US8563307B2 (enExample)
EP (1) EP2400971B1 (enExample)
JP (1) JP5809068B2 (enExample)
CN (1) CN102325537B (enExample)
ES (1) ES2582582T3 (enExample)
TW (1) TWI496888B (enExample)
WO (1) WO2010099044A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
US8741642B2 (en) 2010-10-22 2014-06-03 Virginia Commonwealth University Methods for producing autologous immune cells resistant to myeloid-derived suppressor cells effects
TWI614340B (zh) 2011-09-28 2018-02-11 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
WO2013176785A1 (en) * 2012-05-21 2013-11-28 The Trustees Of Columbia University In The City Of New York Trefoil family factor and uses thereof
CN104822827B (zh) 2012-12-06 2020-01-21 干细胞生物科技公司 Lgr5+体干细胞
EP2746769A1 (en) * 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
US9212225B1 (en) * 2014-07-01 2015-12-15 Amphivena Therapeutics, Inc. Bispecific CD33 and CD3 binding proteins
HK1253512A1 (zh) 2015-05-29 2019-06-21 Amphivena Therapeutics, Inc. 双特异性cd33和cd3结合蛋白质的使用方法

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2936171B2 (ja) 1989-09-01 1999-08-23 東ソー株式会社 血清アルブミンの製造方法
US6004807A (en) 1992-03-30 1999-12-21 Schering Corporation In vitro generation of human dendritic cells
US6916654B1 (en) * 1992-06-29 2005-07-12 Oklahoma Medical Research Foundation Universal donor cells
EP0972039A1 (en) * 1997-03-25 2000-01-19 Morphogenesis, Inc. Universal stem cells
WO1999026639A1 (en) 1997-11-26 1999-06-03 Allegheny University Of The Health Sciences Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
AU3456099A (en) 1998-03-31 1999-10-18 Geron Corporation Methods and compositions for eliciting an immune response to a telomerase antigen
US6080399A (en) 1998-04-23 2000-06-27 Arch Development Corporation Vaccine adjuvants for immunotherapy of melanoma
JP3553858B2 (ja) 1999-08-25 2004-08-11 東洋紡績株式会社 血管網類似構造体を有する細胞培養用モジュール
US20030161817A1 (en) 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US7575921B2 (en) 1999-12-30 2009-08-18 Vbi Technologies, L.L.C. Spore-like cells and uses thereof
US20020151050A1 (en) 2000-10-30 2002-10-17 Vacanti Charles A. Isolation of spore-like cells from tissues exposed to extreme conditions
JP3977136B2 (ja) 2001-05-22 2007-09-19 キヤノン株式会社 コイルユニット
US7316932B2 (en) 2001-10-01 2008-01-08 Stemcell Technologies Inc. Method for separating cells
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
US20070233391A1 (en) 2002-03-07 2007-10-04 Cambridge University Technical Service Limited (CUTS) Scd fingerprints
AU2003241252A1 (en) 2002-06-06 2003-12-22 Immunicum Ab New method and composition for producing a cellular allogeneic vaccine
WO2004042023A2 (en) * 2002-11-01 2004-05-21 Five Prime Therapeutics, Inc. Stem cell libraries
US20060252150A1 (en) * 2002-11-08 2006-11-09 Linzhao Cheng Human embryonic stem cell cultures, and compositions and methods for growing same
US20050003533A1 (en) 2003-05-08 2005-01-06 Pawel Kalinski Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
US20090004661A1 (en) 2003-05-26 2009-01-01 Reliance Life Sciences Pvt Ltd. Method of growing mesenchymal stem cells from bone marrow
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
AU2004249812B8 (en) * 2003-06-25 2011-09-15 Ottawa Hospital Research Institute Methods and compositions for modulating stem cell growth and differentiation
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
EP1789540B9 (en) 2004-09-03 2012-02-22 Moraga Biotechnology Inc. Non-embryonic totipotent blastomer-like stem cells and methods therefor
WO2006070370A2 (en) 2004-12-29 2006-07-06 Hadasit Medical Research Services & Development Limited Stem cells culture systems
US8846395B2 (en) 2005-06-01 2014-09-30 Wisconsin Alumni Research Foundation Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+progenitors
RU2417093C2 (ru) 2005-06-24 2011-04-27 Дезерт Лейк Текнолоджиз Очищенный компонент цианобактерий и способ применения
WO2007026353A2 (en) 2005-08-29 2007-03-08 Technion Research & Development Foundation Ltd. Media for culturing stem cells
US20080305079A1 (en) * 2006-01-06 2008-12-11 Mount Sinai School Of Medicine Of New York University Myeloid Suppressor Cells, Methods For Preparing Them, and Methods For Using Them For Treating Autoimmunity
CA2640087A1 (en) 2006-01-25 2007-08-02 Mount Sinai School Of Medicine Methods and compositions for modulating the mobilization of stem cells
EP1991666A4 (en) 2006-02-27 2009-06-10 Moraga Biotech Corp NON-EMBRYONIC TOTIPOTENT STEM CELLS OF BLASTOMERIC TYPE AND METHODS
AU2007264043B2 (en) 2006-06-27 2012-03-15 Nutratec S.R.L. Extracts of Aphanizomenon Flos Aquae and nutritional, cosmetic and pharmaceutical compositions containing the same
EP1894941A1 (en) * 2006-09-01 2008-03-05 Institut Pasteur Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying HPV antigens
US8759090B2 (en) * 2006-10-30 2014-06-24 University Of Central Florida Research Foundation, Inc. Stem cell banking system
US20090104160A1 (en) 2007-02-01 2009-04-23 Moraga Biotechnology Corporation Mobilization of Stem Cells After Trauma and Methods Therefor
US20090053182A1 (en) 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
ES2694018T3 (es) 2007-07-02 2018-12-17 Oncomed Pharmaceuticals, Inc. Composiciones y métodos para el tratamiento y el diagnóstico del cáncer
CA2693144A1 (en) 2007-07-17 2009-01-22 The General Hospital Corporation Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
CN101978046A (zh) 2007-10-30 2011-02-16 路易斯维尔大学研究基金会有限公司 非常小的胚胎样(vsel)干细胞的应用和分离
CA2692634C (en) 2007-11-09 2014-05-27 Rnl Bio Co., Ltd Method for isolating and culturing adult stem cells derived from human amniotic epithelium
GB2467982A (en) 2008-05-08 2010-08-25 Coretherapix Slu Pluripotent adult stem cells
CN102333861A (zh) 2008-09-30 2012-01-25 路易斯维尔大学研究基金会有限公司 用于分离非常小的胚胎样(vsel)干细胞的方法
WO2010056341A2 (en) 2008-11-12 2010-05-20 The University Of Vermont And State Agriculture College Compositions and methods for tissue repair
CN102333863A (zh) 2009-01-13 2012-01-25 干细胞生物科技公司 非胚胎干细胞及其用途
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US8642339B2 (en) 2009-02-03 2014-02-04 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
WO2011119738A2 (en) 2010-03-23 2011-09-29 The Johns Hopkins University Methods of treatment using stem cell mobilizers
CA2835313A1 (en) 2010-05-07 2011-11-10 Institut De Recherches Cliniques De Montreal Gfi1b modulation and uses thereof
TWI686202B (zh) 2010-08-04 2020-03-01 幹細胞生物科技公司 體幹細胞
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
CN102008650B (zh) 2010-12-16 2017-02-15 天津市医药科学研究所 一种治疗肿瘤的复方中药制剂及其制备方法
TWI614340B (zh) 2011-09-28 2018-02-11 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
CN104822827B (zh) 2012-12-06 2020-01-21 干细胞生物科技公司 Lgr5+体干细胞
JP6581758B2 (ja) 2013-06-24 2019-09-25 ステムバイオス テクノロジーズ,インコーポレイテッド 幹細胞及びそのデータを獲得する方法
CN105687245A (zh) 2014-12-13 2016-06-22 干细胞生物科技公司 制备注射液的方法

Similar Documents

Publication Publication Date Title
NZ701915A (en) High-concentration monoclonal antibody formulations
JP2010280671A5 (enExample)
HRP20180237T4 (hr) Metode za liječenje hcv-a
JP2016517888A5 (enExample)
JP2016034978A5 (enExample)
EA201391521A1 (ru) Композиции и способы для ингибирования и/или модулирования эффекторных t-клеток, участвующих в воспалительном нейродегенеративном заболевании
MX2019010385A (es) Dispositivos, metodos y composiciones utiles en la crio-conservacion, -almacenamiento, -transporte y aplicacion de celulas terapeuticas de mamiferos.
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
RU2015103116A (ru) Новый штамм lactobacillus crispatus
MX2009006786A (es) Composiciones y metodos para el tratamiento de infecciones y tumores.
EP2566535A4 (en) DEVICE FOR ADMINISTERING A BIOACTIVE AGENT
EA202190722A1 (ru) Клинические композиции
EA201490377A1 (ru) Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата
MX357540B (es) Composiciones y metodos para inhibir masp-1 y/o masp-2 y/o masp-3 para el tratamiento de la hemoglobinuria paroxistica nocturna.
PH12014501620A1 (en) Compositions and methods for the treatment of hepatic diseases and disorders
JP2011225596A5 (enExample)
JP2016539156A5 (enExample)
CO6771406A2 (es) Una composición combinada
JP2013541583A5 (enExample)
JP2016516985A5 (enExample)
RU2018125622A (ru) Способ применения карримицина против резистетности инфекции, спровоцированной микобактерией туберкулеза
EA201592040A1 (ru) Иммуногенная композиция для применения в терапии
JP2013523886A5 (enExample)
WO2012177660A3 (en) Leukotoxin e/d as a new anti-inflammatory agent and microbicide
EA201390417A1 (ru) Антидиабетические твердые фармацевтические композиции